Journal of Asthma and Allergy
Volume 16, 2023 - Issue
Open access
262
Views
3
CrossRef citations to date
0
Altmetric
RAPID COMMUNICATION
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
Jorge F Maspero1 Allergy & Respiratory Research Unit, Fundación CIDEA, Buenos Aires, ArgentinaCorrespondence[email protected]
https://orcid.org/0000-0001-9750-2346View further author information
Asif H Khan2 Global Medical Affairs, Sanofi, Chilly-Mazarin, France
https://orcid.org/0000-0001-9158-0116View further author information
Carl Philpott3 Rhinology and ENT Research Group, Norwich Medical School, University of East Anglia, Norwich, UK
https://orcid.org/0000-0002-1125-3236View further author information
Peter W Hellings4 Department of Otorhinolaryngology – Head and Neck Surgery, University Hospitals Leuven, Leuven, BelgiumView further author information
, Claire Hopkins5 Department of Otorhinolaryngology, King’s College London, London, UKView further author information
, Martin Wagenmann6 Department of Otorhinolaryngology, Düsseldorf University Hospital (UKD), Düsseldorf, Germany
https://orcid.org/0000-0002-9734-0241View further author information
Shahid Siddiqui7 Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAView further author information
, Jérôme Msihid8 Health Economics and Value Assessment, Sanofi, Chilly-Mazarin, France
https://orcid.org/0000-0003-4733-5855View further author information
Scott Nash7 Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA
https://orcid.org/0000-0001-9208-5280View further author information
Chien-Chia Chuang9 Health Economics and Value Assessment, Sanofi, Cambridge, MA, USA
https://orcid.org/0000-0002-0895-4998View further author information
Siddhesh Kamat7 Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA
https://orcid.org/0000-0001-5205-9184View further author information
Paul J Rowe10 Global Medical Affairs, Sanofi, Bridgewater, NJ, USAView further author information
, Yamo Deniz7 Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAView further author information
& Juby A Jacob-Nara10 Global Medical Affairs, Sanofi, Bridgewater, NJ, USA
https://orcid.org/0000-0002-5372-8762View further author information
Pages 323-332
|
Received 29 Jun 2022, Accepted 08 Mar 2023, Published online: 29 Mar 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.